Bayer’s Finerenone hits target in Phase III FIDELIO-DKD renal outcomes study The company claims that finerenone is the first investigational non-steroidal, selective mineralocorticoid receptor antagonist to…
Cause or Effect? An Intriguing Connect Between COVID-19 and Non-communicable Diseases in India Pranav Anam, Founder, The Gene Box discusses how Indians suffering from NCDs are predisposed to COVID-19 as India is also the hub…
